Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
SciSparc (SPRC US)
Watchlist
83
Analysis
Health Care
•
Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
01 May 2026 08:01
•
Broker
Krungthai XSpring Zoom Eng. April 30, 2026
The Fed kept its policy rate unchanged at 3.50–3.75%, but divisions within the FOMC have begun to emerge over the wording of the press release.
Krungthai XSpring
Follow
108 Views
Share
bullish
•
Thematic (Sector/Industry)
•
09 Apr 2026 08:31
•
Broker
Krungthai XSpring Zoom Eng. April 8, 2026
The US-Iran: Trump announced a two-week ceasefire with Iran, conditional on reopening the Strait of Hormuz, and stated that the agreement has been...
Krungthai XSpring
Follow
114 Views
Share
bearish
•
Thematic (Sector/Industry)
•
08 Apr 2026 08:09
•
Broker
Energy (Refinery): Government To Overhaul Oil Pricing Structure - Neutral
We assess a case study based on a subsidy contribution assumption, benchmarked against a reduction in refining margins of every USD5/bbl...
Krungthai XSpring
Follow
109 Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 Apr 2026 08:08
•
Broker
Krungthai XSpring Zoom Eng. April 7, 2026
Consumption plays (CPALL, CPAXT) should benefit from stimulus measures following the government’s policy statement on April 9–10.
Krungthai XSpring
Follow
101 Views
Share
bearish
•
Thematic (Sector/Industry)
•
31 Mar 2026 08:25
•
Broker
Krungthai XSpring Zoom Eng. March 30, 2026
The market was pressured by a rebound in oil prices and uncertainty surrounding the US stance.Domestically, continued government efforts to ease...
Krungthai XSpring
Follow
116 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x